You took a while to show up with that observation..."fancy" indeed!! No OTC fish oil is comparable in EPA content or purity or non-oxidized content.
You are likely correct with your MOA comparison. But I sense you know as little about Vascepa as I know about ESPR's medication.
Do you reject my price comparison, and advantage of same in Vascepa's court? Do you disregard the lipid panel results I showed you, including LDL-C and HDL? Do you think that the ESPR medication will demonstrate a similar EPA/AA ratio, or EPA + DHA index value in commercial use, or are those ratios/values unimportant to you? Cardiologists do not reject them as unimportant. I confess ignorance of whether those ratios and indices are achieved by ESPR's medication ....educate me if you can.
News 
Market Data 
Discover 
